Seroma and Hematoma Rates: MAXIGESIC IV vs. Ketorolac in Breast Cancer Surgery (clinicaltrials.gov) - Aug 28, 2024 - P=N/A | N=60 | Not yet recruiting | Sponsor: Seoul National University Hospital
New trial • Surgery • Breast Cancer • Oncology • Solid Tumor
|